Table 1 Information on the occipital nerve stimulator systems implanted
From: Long-term outcomes of occipital nerve stimulation for chronic migraine: a cohort of 53 patients
|  | N = 53 |
|---|---|
ONS Manufacturer | |
 Medtronic | 47 (88.6 %) |
 St Jude | 6 (11.3 %) |
IPG | |
 Standard | 6 (11.3 %) |
 Rechargeable | 24 (45.3 %) |
 Standard changed to rechargeable | 23 (43.4 %) |
Electrodes | |
 Quad | 2 (3.8 %) |
 Octad | 51 (96.2 %) |
IPG Site | |
 Abdomen | 21 (39.36 %) |
 Infraclavicular | 23 (43.4 %) |
 Abdomen moved to infraclavicular | 9 (17.0 %) |